Antonio Carolei
Antonio Carolei
Professor of Neurology
Verified email at univaq.it
TitleCited byYear
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
MR Patel, KW Mahaffey, J Garg, G Pan, DE Singer, W Hacke, G Breithardt, ...
New England Journal of Medicine, 2011
73542011
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
Lancet 348 (9038), 1329-1339, 1996
5664*1996
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind …
HC Diener, J Bogousslavsky, LM Brass, C Cimminiello, L Csiba, M Kaste, ...
Lancet 364 (9431), 331-337, 2004
2426*2004
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1238-1251, 2008
9842008
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
C Marini, F De Santis, S Sacco, T Russo, L Olivieri, R Totaro, A Carolei
Stroke 36, 1115-1119, 2005
8822005
Telmisartan to prevent recurrent stroke and cardiovascular events
S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1225-1237, 2008
8232008
European stroke initiative recommendations for stroke management–update 2003
GE Carlsson, A Möller, C Blomstrand, T Ueda, K Mizushige, K Yukiiri, ...
Cerebrovascular Diseases 16 (4), 311-337, 2003
8172003
NXY-059 for acute ischemic stroke
KR Lees, JA Zivin, T Ashwood, A Davalos, SM Davis, HC Diener, J Grotta, ...
New England Journal of Medicine 354 (6), 588-600, 2006
6602006
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and …
RAFS Investigators.
Am Heart J 159 (3), 340-347.e1., 2010
5082010
Pioglitazone after ischemic stroke or transient ischemic attack
WN Kernan, CM Viscoli, KL Furie, LH Young, SE Inzucchi, M Gorman, ...
New England Journal of Medicine 374 (14), 1321-1331, 2016
5042016
Risk factors for clinically diagnosed Alzheimer disease: A case-control study of an Italian population
LA Amaducci, L Fratiglioni, WA Rocca, C Fieschi, P Livrea, D Pedone, ...
Neurology 36, 922-931, 1986
5031986
Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry
S Sacco, C Marini, D Toni, L Olivieri, A Carolei
Stroke 40 (2), 394-399, 2009
3622009
History of migraine and risk of cerebral ischaemia in young adults
A Carolei, C Marini, G De Matteis, ...
The Lancet (London, England) 347 (9014), 1503-1506, 1996
3591996
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial
KR Lees, K Asplund, A Carolei, SM Davis, HC Diener, M Kaste, ...
The Lancet 355 (9219), 1949-1954, 2000
3412000
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
GJ Hankey, MR Patel, SR Stevens, RC Becker, G Breithardt, A Carolei, ...
The Lancet Neurology 11 (4), 315-322, 2012
3172012
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic …
HC Diener, RL Sacco, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
The Lancet Neurology 7 (10), 875-884, 2008
3042008
Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study
GE Carlsson, A Möller, C Blomstrand, T Ueda, K Mizushige, K Yukiiri, ...
Cerebrovascular Diseases 16 (4), 389-395, 2003
2632003
Efficacy and safety of Rivaroxaban compared with Warfarin among elderly patients with nonvalvular atrial fibrillation in the ROCKET-AF trial
JL Halperin, GJ Hankey, DM Wojdyla, P J.P., Y Lokhnygina, MR Patel, ...
Circulation 130, 138-146, 2014
2622014
The International Stroke Trial (IST): A Randomised Trial of Aspirin, Subcutaneous Heparin, Both, or Neither Among 19,435 Patients with Acute Ischaemic Stroke
KSL Wong, ISTC Group
The Lancet 349 (9065), 1569-1581, 1997
2551997
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
MG Bousser, P Amarenco, A Chamorro, M Fisher, I Ford, KM Fox, ...
The Lancet 377 (9782), 2013-2022, 2011
2192011
The system can't perform the operation now. Try again later.
Articles 1–20